Allarity Therapeutics, Inc. - COM (ALLR)

CUSIP: 016744500

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COM
Total 13F shares
104,487
Share change
+82,621
Total reported value
$122,250
Price per share
$1.17
Number of holders
5
Value change
+$79,322
Number of buys
5
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 016744500?
CUSIP 016744500 identifies ALLR - Allarity Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q4 2024

As of 31 Dec 2024, Allarity Therapeutics, Inc. - COM (ALLR) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,487 shares. The largest 6 holders included Stonepine Capital Management, LLC, GOLDMAN SACHS GROUP INC, CITIGROUP INC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and DANSKE BANK A/S. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.